they simply won't get shares as the hurdle is not met. Its normal that listed company did not perform as good as what their prospectus says. I can accept some delays in revenue or FDA/CE Mark clearance as long as they did not lie or mislead about the effectiveness of the product.
LTI, page-2
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $70.11M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.0¢ | 23.5¢ | $1.189K | 4.958K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5627 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 10000 | 1 |
View Market Depth
| Last trade - 15.44pm 16/08/2024 (20 minute delay) ? |
| NXS (ASX) Chart |